Browse > Article
http://dx.doi.org/10.3746/pnf.2013.18.3.157

Effects of the Cynanchum wilfordii Ethanol Extract on the Serum Lipid Profile in Hypercholesterolemic Rats  

Lee, Hye-Sung (Department of Culinary Science and Food Service Management, Kyung Hee University)
Choi, Jun-Hyeok (Department of Food Science, Keimyung University)
Kim, Young-Eon (Division of Metabolism and Functionality Research, Functionality Evaluation Research Group, Korea Food Research Institute)
Kim, In-Ho (Division of Metabolism and Functionality Research, Functionality Evaluation Research Group, Korea Food Research Institute)
Kim, Byoung-Mok (Division of Metabolism and Functionality Research, Functionality Evaluation Research Group, Korea Food Research Institute)
Lee, Chang-Ho (Division of Metabolism and Functionality Research, Functionality Evaluation Research Group, Korea Food Research Institute)
Publication Information
Preventive Nutrition and Food Science / v.18, no.3, 2013 , pp. 157-162 More about this Journal
Abstract
The purpose of this study was to investigate the effects of the ethanol extract of Cynanchum wilfordii (ECW) on the blood lipid profile of hypercholesterolemic rats. Thirty 7-week-old male Sprague-Dawley rats were allowed free access to either a normal diet (AIN-93 diet), or 1% high-cholesterol diet with or without 0.5% or 1% ECW for 5 weeks. After sacrifice, the rat serum lipid profile was analyzed. The diets containing ECW decreased body weight gains compared to the normal diet. Serum HDL-cholesterol levels of ECW-fed groups were significantly increased in the hypercholesterolemic groups and normal groups (P<0.05). When 1% ECW was fed to the normal group, total cholesterol level was increased. Moreover, treatment of ECW in hypercholesterolemic groups yielded a dose-dependent and highly significant decrease in the atherogenic index as compared to the control. These results suggest that intake of Cynanchum wilfordii may help reduce the risks of hypercholesterolemia by increasing blood HDL-cholesterol and lowering the atherogenic index.
Keywords
atherogenic index; Cynanchum wilfordii; HDL-cholesterol; hypercholesterolemia; LDL-cholesterol;
Citations & Related Records
Times Cited By KSCI : 1  (Citation Analysis)
연도 인용수 순위
1 Nissen SE, Tuzcu EM, Schoenhagen P, Brown BG, Ganz P, Vogel RA, Crowe T, Howard G, Cooper CJ, Brodie B, Grines CL, DeMaria AN. 2004. Effect of intensive compared with moderate lipid-lowering therapy on progression of coronary atherosclerosis. JAMA 291: 1071-1080.   DOI   ScienceOn
2 Hodel C. 2002. Myopathy and rhabdomyolysis with lipidlowering drugs. Toxicol Lett 128: 159-168.   DOI   ScienceOn
3 Moosmann B, Behl C. 2004. Selenoprotein synthesis and side-effects of statins. Lancet 363: 892-894.   DOI   ScienceOn
4 Jeppesen U, Gaist D, Smith T, Sindrup SH. 1999. Statins and peripheral neuropathy. Eur J Clin Pharmacol 54: 835-838.   DOI
5 Omar MA, Wilson JP. 2002. FDA adverse event reports on statin-associated rhabdomyolysis. Ann Pharmacother 36: 288-295.   DOI   ScienceOn
6 Phan T, McLeod JG, Pollard JD, Peiris O, Rohan A, Halpern JP. 1995. Peripheral neuropathy associated with simvastatin. J Neurol Neurosurg Psychiatry 58: 625-628.   DOI   ScienceOn
7 Chong PH, Boskovich A, Stevkovic N, Bartt RE. 2004. Statin-associated peripheral neuropathy: Review of the literature. Pharmacotherapy 24: 1194-1203.   DOI   ScienceOn
8 Baker SK, Tarnopolsky MA. 2001. Statin myopathies: pathophysiologic and clinical perspectives. Clin Invest Med 24: 258-272.
9 Shan L, Jiu RH, Shen YH, Zhang WD, Zhang C, Wu DZ, Su J, Xu XK. 2006. Gastroprotective effect of a traditional Chinese herbal drug "Baishouwu" on experimental gastric lesions in rats. J Ethnopharmacol 3: 389-394.
10 Kim HS. 2004. Effects of Cynanchum wilfordii extract on serum lipid components and enzyme activities in hyperlipidemic and streptozotocin-induced diabetic rats. Korean J of Human Ecology 7: 1-11.   과학기술학회마을
11 Choi DH, Lee YJ, Kim EJ, Li X, Kim HY, Hwang SM, Yoon JJ, Lee SM, Min EK, Kang DG, Lee HS. 2010. Ethanol extract of Cynanchum wilfordii produces endothelium-dependent relaxation in rat aorta and anti-inflammatory activity in human aortic smooth muscle cells. Journal of Korean Oriental Medicine 31: 45-57.   과학기술학회마을
12 Yoon MY, Choi NH, Min BS, Choi GJ, Choi YH, Jang KS, Han SS, Cha BC, Kim JC. 2011. Potent in vivo antifungal activity against powdery mildews of pregnane glycosides from the roots of Cynanchum wilfordii. J Agric Food Chem 59: 12210- 12216.   DOI   ScienceOn
13 Reeves PG, Nielsen FG, Fahey GC Jr. 1993. AIN-93 purified diets for laboratory rodents: final report of the American institute of nutrition ad hoc writing committee on the reformulation of the AIN-76A rodent diet. J Nutr 123: 1939-1951.   DOI
14 Anderson JW, Jones AE, Riddel-Mason S. 1994. Ten different dietary fibers have significantly different effects on serum and liver lipids of cholesterol-fed rats. J Nutr 124: 78-83.   DOI
15 Kim HS. 2004. Effects of Cynanchum wilfordii extract on serum lipid components and enzyme activities in hyperlipidemic and streptozotocin-induced diabetic rats. Korean J Human Ecology 7: 1-11.   과학기술학회마을
16 Kannel WB. 2000. The Framingham study: Its 50-year legacy and future promise. J Atheroscler Thromb 6: 60-66.   DOI
17 Tapsell LC, Gillen LJ, Patch CS, Batterham M, Owen A, Bare M, Kennedy M. 2004. Including walnuts in low-fat/ modified-fat improves HDL-cholesterol-to-total cholesterol ratios in patients with type 2 diabetes. Diabetes Care 12: 2777-2783.
18 Barter P, Gotto AM, LaRosa JC, Maroni J, Szarek M, Grundy SM, Kastelein JJ, Bittner V, Fruchart JC. 2007. HDL cholesterol, very low levels of LDL cholesterol, and cardiovascular events. N Eng J Med 357: 1301-1310.   DOI   ScienceOn
19 Scandinaviasn Simvastin Survival Study Group. 1994. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). Lancet 344: 1383-1389.
20 Downs JR, Clearfield M, Weis S, Whitney E, Shapiro DR, Beere PA, Langendorfer A, Stein EA, Kruyer W, Gotto AM. 1998. Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels. JAMA 279: 1615-1622.   DOI   ScienceOn
21 Whitney E, Rolfes SR. 2005. Understanding nutrition. 10th ed. Thomson Wadsworth, Belmont, CA, USA. p 622-623.
22 Assmann G, Schulte H, Eckardstein AV, Huang Y. 1996. High-density lipoprotein cholesterol as a predictor of coronary heart disease risk: the PROCAM experience and pathophysiological implications for reverse cholesterol transport. Atherosclerosis 124: S11-S20.   DOI   ScienceOn
23 Curb JD, Abbott RD, Rodriguez BL, Masaki K, Chen R, Sharp DS, Tall AR. 2004. A prospective study of HDL-C and cholesteryl ester transfer protein gene mutations and the risk of coronary heart disease in the elderly. J Lipid Res 45: 948-953.   DOI   ScienceOn
24 Gordon T, Castelli WP, Hjortland MC, Kannel WB, Dawber TR. 1977. High density lipoprotein as a protective factor against coronary heart disease: the Framingham Study. Am J Med 62: 707-714.   DOI   ScienceOn
25 Sharret AR, Ballabtyne CM, Coady SA, Heiss G, Sorlie PD, Catellier D, Oatsch W. 2001. Coronary heart disease prediction from lipoprotein cholesterol levels, triglycerides, lipoprotein(a), apolipoproteins A-I and B, and HDL density subfractions: the Atherosclerosis Risk in Communities (ARIC) Study. Circulation 104: 1108-1113.   DOI   ScienceOn
26 Chapman MJ. 2006. Therapeutic elevation of HDL-cholesterol to prevent atherosclerosis and coronary heart disease. Pharmacol Therapeut 111: 893-908.   DOI   ScienceOn
27 Sang CJ, Yong TJ, Byung KY, Rezuanul I, Sundar RK, Gerald P, Kai YC, Chi HS. 2009. White button mushroom (Agarieus bisporus) lowers blood glucose and cholesterol levels in diabetic and hypercholesterolemic rats. Nutr Res 30: 49-56.
28 Ahmed F, Waslien C, Al-Sumaie M. 2012. Trends and risk factors of hypercholesterolemia among Kuwaiti adults: National nutrition surveillance data from 1998 to 2009. Nutrition 28: 917-923.   DOI   ScienceOn
29 Basu S, McKee M, Galea G, Stuckler D. 2013. Relationship of soft drink consumption to global overweight, obesity, and diabetes: A Cross-National Analysis of 75 Countries. Am J public health doi: 10.2105/AJPH.2012.300974.   DOI
30 KCDC. 2010. Korea national health and nutrition examination survey (KNHANES V-1). Korea centers for disease control and prevention, Chungcheongbuk-do, Korea.
31 Pyorala K, De Backer G, Graham I, Poole-Wilson P, Wood D. 1994. Prevention of coronary heart disease in clinical practice: recommendations of the task force of the European society of cardiology, European atherosclerosis society and European society of hypertension. Eur Heart J 15: 1300-1331.   DOI
32 Sacks FM, Pfeffer MA, Moye LA, Rouleau JL, Rutherford JD, Cole TG, Brown L, Warnica JW, Arnold JM, Wun CC, Davis BR, Braunwald E. 1996. The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. N Engl J Med 335: 1001-1009.   DOI   ScienceOn
33 Shepherd J, Cobbe SM, Ford I, Isles CG, lorimer R, Macfariane PW, McKoillop JH, Packard CJ. 1995. Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. N Engl J Med 333: 1301-1308.   DOI   ScienceOn
34 Cannon CP, Braunwald E, McCabe CH, Rader DJ, Rouleau JL, Belder R, Joyal SV, Hill KA, Pfeffer MA, Skene AM. 2004. Intensive versus moderate lipid lowering with statins after acute coronary syndromes. N Engl J Med 350: 1495-1504.   DOI   ScienceOn
35 Castelli WP, Garrison RJ, Wilson PWF, Abbott RD, Kalousdian S, Kannel WB. 1986. Incidence of coronary heart disease and lipoprotein cholesterol Levels. The Framingham Study. JAMA 256: 2835-2838.   DOI   ScienceOn